Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 09, 2022
PharmaLex Group has announced a merger with Italy-based EBMA Consulting, a specialist consultancy company focused on strategic pricing, market access and health economics services for the life sciences.
read more
Tuesday, January 25, 2022
Founded in 1997, Phlexglobal provides its industry-leading and innovative electronic Trial Master File platform (PhlexTMF) and services to hundreds of global life sciences companies and AI-enabled automation solutions that allow customers to benefit ...
read more
PharmaLex has completed the merger of Biopharma Excellence GmbH.
read more
PharmaLex Group has completed the merger with BioStat Solutions, Inc. (BSSI).
read more
Friday, February 26, 2021
PharmaLex Group has completed the acquisition of ERA Consulting (ERA).
read more
Tuesday, December 07, 2021
PharmaLex Group, a provider of specialized services for the pharma, biotech and medtech industries worldwide, announced a merger with pharmasol, a global life sciences organization focused on pharmacovigilance IT and business support.
read more
PharmaLex Group has added Sébastien Schmitt to the company’s senior management team.
read more
Friday, September 02, 2022
PharmaLex Group has announced the opening of a new branch in Beijing, China, giving global clients access to a team of regulatory experts in the region.
read more
Tuesday, September 17, 2024
PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO).
read more
Tuesday, January 21, 2025
PharmAla Biotech Holdings Inc. has executed an agreement with Merhavim Mental Health Centre of Beer Yaakov, Israel.
read more
PharmAla Biotech Holdings Inc. has contracted with a third-party logistics company specializing in pharmaceutical products to function as its US clinical trial distribution partner.
read more
Wednesday, October 12, 2022
PharmAla Biotech has retained Clerkenwell Health, a UK-based Contract Research Organization, to assist PharmAla in regulatory proceedings with both the FDA and the UK Medicines and Health Regulatory Authority (MHRA).
read more
Tuesday, February 20, 2018
PharmaJet announced a global license agreement with Genexine for the development and commercialization of DNA vaccines for human applications.
read more
Thursday, September 12, 2024
PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology ...
read more
Thursday, January 08, 2026
PharmaForceIQ announced its acquisition of Aktana, aligning its digital orchestration platform with an AI-driven field Next-Best-Action (NBA) platform.
read more